Pipobroman

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

Key facts

Pipobroman is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1966.

• Approval status: ofm (first approved 1966 by the FDA).
• ATC code: L01AX02 (Other alkylating agents).
• Molecular formula: C10H16Br2N2O2; molecular weight 356.06 g/mol.

Regulatory approvals (1)

Date	Agency	Marketed as	Applicant	Orphan
1966-07-01	FDA	—	—

ATC classification

ATC code	Therapeutic hierarchy
L01AX02	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS › ANTINEOPLASTIC AGENTS › ALKYLATING AGENTS › Other alkylating agents

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Pipobroman is on its molecule page.

• Molecular formula: C₁₀H₁₆Br₂N₂O₂
• Molecular weight: 356.06 g/mol
• CAS number: 54-91-1
• InChIKey: NJBFOOCLYDNZJN-UHFFFAOYSA-N
• PubChem CID: 4842

BrCCC(=O)N1CCN(CC1)C(=O)CCBr

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

When was Pipobroman first approved?

Pipobroman was first approved by the FDA in 1966.

What is the chemical formula of Pipobroman?

Pipobroman has the molecular formula C10H16Br2N2O2 and a molecular weight of 356.06 g/mol.

Sources

• DrugCentral drug card 2192 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL1585 — compound record and bioactivity
• PubChem CID 4842 — chemical identifiers
• DrugBank DB00236 — drug record
• FDA UNII 6Q99RDT97R — substance identity
• DailyMed: FDA labels for Pipobroman — current prescribing information (label search)

How this page is built: methodology · editorial policy & corrections.